Boston Scientific Corporation BSX-PA NYSE

Boston Scientific Corporation (BSX-PA) 报告总资产为 $43.67B 总负债为 $19.2B 財年 2025, 总权益为 $24.47B.

公司持有 $2.05B 现金及短期投资. 总债务为 $12.42B, 净债务为 $10.37B. D/E比率为 0.51 (适中的).

流动比率为 1.62, 表明短期流动性强. 利息覆蓋率为 11.4x (强劲的).

本页支持的标准:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.51, current ratio of 1.62, interest coverage 11.4x — 资产负债表强劲
• MOAT (86/100) — 总资产 $43.67B 和 equity $24.47B 支持公司的竞争规模
• VALUE (15/100) — Debt-to-Equity 0.51 影响整体估值风险评估

SharesGrow 收入评分: 76/100 其中 5/7 项标准通过.

C-PK

Citigroup Inc.

$24.99

-0.04%

APTV-PA

Aptiv PLC

$108.66

+0.15%

BDXB

Becton, Dickinson and Company

$48.16

+1.39%

CFG-PE

Citizens Financial Group, Inc.

$19.03

+0.32%

DLR-PL

Digital Realty Trust, Inc.

$19.87

+0.65%

LLY

Eli Lilly and Company

$922.50

-0.76%

JNJ

Johnson & Johnson

$240.10

+0.90%

ABBV

AbbVie Inc.

$210.32

+1.86%